Effect of palivizumab on respiratory syncytial virus-associated hospitalization rates
Latest Information Update: 01 Jun 2021
At a glance
- Drugs Palivizumab (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 01 Jun 2021 New trial record